简体中文 | 繁體中文 | English

IPO News

2019-12-16 11:57 OneConnect Announces Pricing of Initial Public Offering
2019-11-20 18:10 Alibaba Group Announces Pricing of Global Offering
2019-11-15 09:41 Alibaba Group Launches Hong Kong Initial Public Offering
2019-11-14 09:27 OneConnect Announces Public Filing of Registration Statement for Proposed Initial Public Offering
2019-10-23 16:40 Union Acquisition Corp. II Announces Closing of $200 Million Initial Public Offering
2019-10-21 14:02 ADX Group Announces IPO Progress, New Cyber Security Offerings
2019-09-17 18:35 Statement From The We Company
2019-08-19 18:03 FINEOS lists on the Australian Securities Exchange
2019-08-15 14:40 The We Company Files Registration Statement for Proposed Initial Public Offering
2019-08-05 09:46 AMTD International Inc. Announces Pricing of Initial Public Offering
2019-05-17 16:28 London Stock Exchange Welcomes Finablr PLC to the Main Market
2019-04-30 15:34 The We Company Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
2019-04-19 16:58 KCI Files Registration Statement for Proposed Initial Public Offering
2019-04-10 15:01 Alcon Debuts as Independent, Publicly Traded Company
2019-02-27 18:39 China Driving eSIM Adoption Says New GSMA Report
2019-02-27 10:32 Visa and Planeta Informatica Pioneer New Technology to Bring the Speed, Security and Convenience of Contactless Payments to Transit Operators Around the World
2018-12-20 13:34 Takeda Announces Listing of American Depositary Shares on the New York Stock Exchange
2018-12-07 15:37 Aptorum Group Limited Announces Pricing of Initial Public Offering
2018-11-13 13:52 Appellate Court to Consider Rimini Street Appeal of Injunction
2018-11-06 09:53 Initial results from EMPRISE real-world evidence study shows empagliflozin was associated with reduced risk for hospitalisation for heart failure compared with DPP-4 inhibitors in people with type 2 diabetes with and without cardiovascular disease

Business Wire Weibo

Press Releases

Latest Releases